Property:Metabolization
From Psychiatrienet
(Created page with 'Metabolization is defined within this context as a property of a drug, and will be displayed on combination pages. Has type::String') |
|||
| Line 1: | Line 1: | ||
Metabolization is defined within this context as a property of a drug, and will be displayed on combination pages. | Metabolization is defined within this context as a property of a drug, and will be displayed on combination pages. | ||
| − | [[Has type:: | + | [[Has type::Text]] |
Latest revision as of 10:40, 21 April 2010
Metabolization is defined within this context as a property of a drug, and will be displayed on combination pages. Text
A
*Aripiprazole is metabolized by CYP2D6 and CYP3A4 to an active metabolite.
+
*Aripiprazole is metabolized by CYP2D6 and CYP3A4 to an active metabolite.
+
C
* Carbamazepine is principally metabolized by CYP3A4, and is a potent inducer of CYP1A2, CYP2C9, CYP3A4 and UDP-glucuronosyltransferases.
+
G
* Gabapentin is eliminated unchanged by the kidney for 100%.
+
L
* Lamotrigine is principally metabolised by UDP-glucuronosyltransferases.
+
* Lithium is eliminated by the kidney for about 95%. Changes in the rate of excretion can cause unwanted effects.
+
O
* Olanzapine is principally metabolized by CYP1A2 and CYP2D6.
+
Q
* Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites.
+
R
* Risperidone is principally metabolized by CYP2D6 to an active metabolite 9-OH-risperidone (paliperidone).
+
T
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
+
V
* Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic acid is an inhibitor of the enzymes CYP2C9, epoxide-hydroxylase and UDP-glucuronosyltransferases.
+
Z
* Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.
+
